Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Dixon

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Oncology (Williston Park, N.Y.)|April 1, 1990
Prognostic factors and clinical trialsD O Dixon
Controlled Clinical Trials|June 1, 1989
Assessing new cancer treatments: regarding T. M. Morgan's "Analysis of Duration of Response"D O Dixon
Statistics in Medicine|January 15, 1992
Bayesian subset analysis in a colorectal cancer clinical trialD O Dixon, R Simon
Controlled Clinical Trials|October 9, 2001
Coping with multiple testingD O Dixon, G Pennello
Journal of Clinical Epidemiology|January 1, 1988
Sample size considerations for studies comparing survival curves using historical controlsD O Dixon, R Simon
Biometrics|September 1, 1991
Bayesian subset analysisD O Dixon, R Simon
Cancer Treatment and Research|January 1, 1995
Issues in the design and analysis of AIDS clinical trialsD O Dixon, J M Albert
Controlled Clinical Trials|February 5, 2000
Should data and safety monitoring boards share confidential interim data?D O Dixon, S W Lagakos
Cancer Treatment Reports|April 1, 1982
Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followupC A Coltman, D O Dixon
Statistics in Medicine|July 1, 1987
Multiple comparisons for relative risk regression: extension of the kappa-ratio methodD O Dixon, G W Divine
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|April 1, 1990
Prognostic factors and clinical trialsD O Dixon
Controlled Clinical Trials|June 1, 1989
Assessing new cancer treatments: regarding T. M. Morgan's "Analysis of Duration of Response"D O Dixon
Statistics in Medicine|January 15, 1992
Bayesian subset analysis in a colorectal cancer clinical trialD O Dixon, R Simon
Controlled Clinical Trials|October 9, 2001
Coping with multiple testingD O Dixon, G Pennello
Journal of Clinical Epidemiology|January 1, 1988
Sample size considerations for studies comparing survival curves using historical controlsD O Dixon, R Simon
Biometrics|September 1, 1991
Bayesian subset analysisD O Dixon, R Simon
Cancer Treatment and Research|January 1, 1995
Issues in the design and analysis of AIDS clinical trialsD O Dixon, J M Albert
Controlled Clinical Trials|February 5, 2000
Should data and safety monitoring boards share confidential interim data?D O Dixon, S W Lagakos
Cancer Treatment Reports|April 1, 1982
Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followupC A Coltman, D O Dixon
Statistics in Medicine|July 1, 1987
Multiple comparisons for relative risk regression: extension of the kappa-ratio methodD O Dixon, G W Divine
Pageof 6